Hiruy Meharena received his PhD in biomedical sciences from the University of California, San Diego. Dr. Meharena specializes in integrating genomics, biophysics, biochemistry, computational biology and molecular biology to understand and design therapeutic avenues for neurological disorders. His graduate school research focused on understanding the atomic principles governing a family of proteins known as Eukaryotic Protein Kinases to identify and design novel therapeutic avenues for various cancers under the mentorship of Dr. Susan Taylor. After completing graduate school, he transitioned into neuroscience research where he currently focuses on decoding the genetic and molecular mechanisms regulating neurological processes and specifically studying the alteration of these processes in Down syndrome under the mentorship of Dr. Li-Huei Tsai. He currently utilizes patient derived stem cell technology as well as mouse models to decipher the consequences of Trisomy 21 on the 3D-genome architecture and identify novel therapeutic targets for individuals with Down syndrome.